The main purpose of this legislation is to repeal a specific part of an existing law related to drug policy. The goal is to update and improve the approach to drug control in the United States by removing outdated provisions that may not align with current evidence-based practices. The key provision of this legislation is the repeal of section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998. This section likely contains guidelines or requirements that are now considered ineffective or counterproductive in addressing drug-related issues.